Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.9M
-
Number of holders
-
171
-
Total shares
-
54.2M
-
Shares change
-
+745K
-
Total reported value, excl. options
-
$2.03B
-
Value change
-
+$29.5M
-
Number of buys
-
74
-
Number of sells
-
-85
-
Price
-
$37.42
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2014
171 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q4 2014.
HAEMONETICS CORP - Common Stock (HAE) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.2M shares
.
Largest 10 shareholders include Neuberger Berman Group LLC (4.89M shares), VANGUARD GROUP INC (3.48M shares), BlackRock Fund Advisors (2.89M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2.35M shares), FMR LLC (2.28M shares), WESTWOOD HOLDINGS GROUP INC (1.9M shares), VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. (1.75M shares), Black Creek Investment Management Inc. (1.48M shares), WELLINGTON MANAGEMENT GROUP LLP (1.4M shares), and Van Berkom & Associates Inc. (1.35M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.